bufalin (MedChemExpress)
Structured Review
Bufalin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-n0877/Bufalin/pmc12776075-54-0-5
Average 94 stars, based on 18 article reviews
Images
Related Articles
Binding Assay:Article Title: Bufalin reverses oxaliplatin resistance in gastric cancer by targeting YBX1 to suppress glycolysis. Article Snippet: Oxaliplatin resistance is a key challenge in gastric cancer therapy.. This study explored how bufalin, an active component of Chansu, reverses this resistance.. We found that bufalin targets the transcription factor YBX1, which is upregulated in resistant cells. other:Article Title: Bufalin: a potential drug for regulating EGFR-TKIs resistance in lung cancer via the EGFR-PI3K/Akt-mTOR signaling Article Snippet: Bufalin was obtained from the CCK-8 Assay:Article Title: Bufalin reverses oxaliplatin resistance in gastric cancer by targeting YBX1 to suppress glycolysis. Article Snippet: Oxaliplatin resistance is a key challenge in gastric cancer therapy.. This study explored how bufalin, an active component of Chansu, reverses this resistance.. We found that bufalin targets the transcription factor YBX1, which is upregulated in resistant cells. |
